| Cobicistat;Elvitegravir;Emtricitabine;Tenofovir Disoproxil Fumarate | Gilead | ||
| 150mg; 150mg; 200mg; 300mg; Tablet, Oral |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
None | ||
| None | None | ||
| Used as a complete regimen for the treatment of HIV-1 infection | |||
|
Yes
| |||
| Stribild | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ***** | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| *** ** ***** ******* ********* ** ******* *** ************** ** * ************** ***** | ********* ******** *** ********** ** *-*************-*-(*-*************-*-**)-*,*-*********** | ****** ** ********** *** ********* ******** ** *,*-*********** *********** *********** | *-************ ******** *** *** ******* ** ************** ***** | ****** ******* ** *-************ ******** | ********** ** *************** ********** ** ************ | ************ *** ******* *** *********** ********* ******* | *********** ******* | ************ *** ******* *** *********** ********* ******* | ****** ******* ** *-************ ******** | ************ *** ******* *** *********** ********* ******* | ************ *** ******* *** *********** ********* ******* | ********** ** *************** ********** ** ************ |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ***** | *** \ ********* | **** **, **** | ******* | **** | ***** **** **** (******** ******) |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|